Published in Semin Oncol on April 01, 2001
Administration of zoledronic acid enhances the effects of docetaxel on growth of prostate cancer in the bone environment. BMC Cancer (2006) 1.23
Bone histology at autopsy and matched bone scintigraphy findings in patients with hormone refractory prostate cancer: the effect of bisphosphonate therapy on bone scintigraphy results. Clin Exp Metastasis (2003) 1.22
Zoledronic acid induces antiproliferative and apoptotic effects in human pancreatic cancer cells in vitro. Br J Cancer (2003) 1.21
Effect of zoledronate on oral wound healing in rats. Clin Cancer Res (2010) 0.98
Ibandronate in osteoporosis: preclinical data and rationale for intermittent dosing. Osteoporos Int (2004) 0.94
Once-yearly zoledronic acid in hip fracture prevention. Clin Interv Aging (2009) 0.86
Assessment of bone quality using finite element analysis based upon micro-CT images. Clin Orthop Surg (2009) 0.84
Nitrogen-containing bisphosphonates inhibit cell cycle progression in human melanoma cells. Br J Cancer (2004) 0.82
A new concept for bisphosphonate therapy: a rationale for the development of monthly oral dosing of ibandronate. Osteoporos Int (2005) 0.82
Activated protein C differentially regulates both viability and differentiation of osteoblasts mediated by bisphosphonates. Exp Mol Med (2013) 0.80
CCN1, a candidate target for zoledronic acid treatment in breast cancer. Mol Cancer Ther (2011) 0.79
Establishment of an Animal Model of Bisphosphonate-Related Osteonecrosis of the Jaws in Spontaneously Diabetic Torii Rats. PLoS One (2015) 0.78
Differential effect of zoledronic acid on human vascular smooth muscle cells. J Surg Res (2012) 0.77
Once-yearly zoledronic acid in the prevention of osteoporotic bone fractures in postmenopausal women. Clin Interv Aging (2008) 0.77
Zoledronate reverses mandibular bone loss in osteoprotegerin-deficient mice. Osteoporos Int (2008) 0.76
In vivo effects of two novel ALN-EP4a conjugate drugs on bone in the ovariectomized rat model for reversing postmenopausal bone loss. Osteoporos Int (2015) 0.75
Bisphosphonates Inhibit Pain, Bone Loss, and Inflammation in a Rat Tibia Fracture Model of Complex Regional Pain Syndrome. Anesth Analg (2016) 0.75
Zoledrinic Acid Induces Steoblastic Differentiation of Mesenchymal Stem Cells without Change in Hypomethylation Status of OSTERIX Promoter. Cell J (2012) 0.75
Effects of Zoledronate on Mortality and Morbidity after Surgical Treatment of Hip Fractures. Adv Orthop (2016) 0.75
Bisphosphonate inhibits the expression of cyclin A2 at the transcriptional level in normal human oral keratinocytes. Int J Mol Med (2017) 0.75